Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Nature Metabolism|November 17, 2023
Vitamin B<sub>12</sub> is a limiting factor for induced cellular plasticity and tissue repairMarta Kovatcheva, Elena Melendez, Dafni Chondronasiou, et al.
Elife|April 8, 2020
Post-translational regulation of retinal IMPDH1 in vivo to adjust GTP synthesis to illumination conditionsAnna Plana-Bonamaisó, Santiago López-Begines, David Fernández-Justel, et al.
Cardiovascular Diabetology|April 2, 2025
Lipidomic analysis reveals metabolism alteration associated with subclinical carotid atherosclerosis in type 2 diabetesMaria Barranco-Altirriba, Joana Rossell, Núria Alonso, et al.
Pharmacological Research|January 11, 2026
FASN targeting by G28UCM impairs mitochondrial fatty acid synthesis and reveals a FASN-SDHB Synthetic InteractionNastasia Wilfinger-Lutz, Kristina M Kuehrer, Maria J Bueno, et al.
Briefings in Bioinformatics|February 13, 2026
ChemEmbed: a deep learning framework for metabolite identification using enhanced MS/MS data and multidimensional molecular embeddingsMuhammad Faizan-Khan, Roger Giné, Josep M Badia, et al.
Frontiers in Physiology|June 25, 2019
Dysfunctional LAT2 Amino Acid Transporter Is Associated With Cataract in Mouse and HumansEmilia Boiadjieva Knöpfel, Clara Vilches, Simone M R Camargo, et al.
Frontiers in Endocrinology|December 19, 2025
Guanine and pregnenolone sulfate are associated with incident type 2 diabetes in two independent populationsMaria Barranco-Altirriba, Minerva Granado-Casas, Oscar Yanes, et al.
JCI Insight|March 8, 2019
Epigenetic loss of the endoplasmic reticulum-associated degradation inhibitor SVIP induces cancer cell metabolic reprogrammingPere Llinàs-Arias, Margalida Rosselló-Tortella, Paula López-Serra, et al.
Cancer Discovery|December 23, 2020
Endogenous Retroelement Activation by Epigenetic Therapy Reverses the Warburg Effect and Elicits Mitochondrial-Mediated Cancer Cell DeathVicente Fresquet, Maria J Garcia-Barchino, Marta Larrayoz, et al.
EMBO Molecular Medicine|May 14, 2020
Tumors defective in homologous recombination rely on oxidative metabolism: relevance to treatments with PARP inhibitorsÁlvaro Lahiguera, Petra Hyroššová, Agnès Figueras, et al.
Pageof 4